Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W4206434374', 'doi': 'https://doi.org/10.1111/dom.14640/v1/review1', 'title': 'Review for "Efficacy and safety of high‐dose GLP ‐1, GLP ‐1/ GIP and GLP ‐1/glucagon receptor agonists in type 2 diabetes"', 'display_name': 'Review for "Efficacy and safety of high‐dose GLP ‐1, GLP ‐1/ GIP and GLP ‐1/glucagon receptor agonists in type 2 diabetes"', 'publication_year': 2021, 'publication_date': '2021-09-06', 'ids': {'openalex': 'https://openalex.org/W4206434374', 'doi': 'https://doi.org/10.1111/dom.14640/v1/review1'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/dom.14640/v1/review1', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'peer-review', 'type_crossref': 'peer-review', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 58}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11339', 'display_name': 'Role of AMP-Activated Protein Kinase in Cellular Metabolism', 'score': 0.992, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12539', 'display_name': 'Pharmacological Management of Obesity', 'score': 0.9881, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/type-2-diabetes', 'display_name': 'Type 2 Diabetes', 'score': 0.563887}, {'id': 'https://openalex.org/keywords/glucose-control', 'display_name': 'Glucose Control', 'score': 0.553903}, {'id': 'https://openalex.org/keywords/glycemic-control', 'display_name': 'Glycemic Control', 'score': 0.536156}, {'id': 'https://openalex.org/keywords/insulin-signaling', 'display_name': 'Insulin Signaling', 'score': 0.524168}, {'id': 'https://openalex.org/keywords/lipase-inhibitors', 'display_name': 'Lipase Inhibitors', 'score': 0.506214}], 'concepts': [{'id': 'https://openalex.org/C185280430', 'wikidata': 'https://www.wikidata.org/wiki/Q14909910', 'display_name': 'Glucagon-like peptide 1 receptor', 'level': 4, 'score': 0.8455998}, {'id': 'https://openalex.org/C2776398474', 'wikidata': 'https://www.wikidata.org/wiki/Q424611', 'display_name': 'Glucagon-like peptide-1', 'level': 4, 'score': 0.7728283}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.6278095}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5979743}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5841023}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.5689103}, {'id': 'https://openalex.org/C2781308992', 'wikidata': 'https://www.wikidata.org/wiki/Q2526479', 'display_name': 'Liraglutide', 'level': 4, 'score': 0.50024176}, {'id': 'https://openalex.org/C2778563252', 'wikidata': 'https://www.wikidata.org/wiki/Q170617', 'display_name': 'Glucagon', 'level': 3, 'score': 0.46706185}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.3653521}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.3429443}, {'id': 'https://openalex.org/C2778938600', 'wikidata': 'https://www.wikidata.org/wiki/Q389934', 'display_name': 'Agonist', 'level': 3, 'score': 0.16986948}, {'id': 'https://openalex.org/C2779306644', 'wikidata': 'https://www.wikidata.org/wiki/Q2002370', 'display_name': 'Insulin', 'level': 2, 'score': 0.16584799}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/dom.14640/v1/review1', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4300669065', 'https://openalex.org/W4300433033', 'https://openalex.org/W4206203435', 'https://openalex.org/W3030120986', 'https://openalex.org/W2977447459', 'https://openalex.org/W2510267632', 'https://openalex.org/W2490399744', 'https://openalex.org/W2370701043', 'https://openalex.org/W2334271056', 'https://openalex.org/W2109274758'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4206434374', 'counts_by_year': [], 'updated_date': '2024-09-15T07:54:10.500836', 'created_date': '2022-01-25'}